The Netherlands to launch cannabis legalisation pilot December 2023

By |2023-09-20T03:20:09+01:0020 September 2023|

Dutch officials have announced that the country’s cannabis legalisation experiment will begin its pilot phase before the end of the year. Initially approved by the senate in 2019, the Wietexperiment [Weed Experiment] will see a select number of cultivators permitted to supply legal cannabis to coffee [...]

Comments Off on The Netherlands to launch cannabis legalisation pilot December 2023

Endocannabinoid system could be key in treating stress-related conditions – study

By |2023-09-20T03:19:58+01:0020 September 2023|

New findings related to how the body’s endocannabinoid system responds to stress could open a new avenue of drug development to treat psychiatric disorders, say researchers.  Scientists believe that when an individual is under stress the brain may release its own cannabinoid molecules to calm them [...]

Comments Off on Endocannabinoid system could be key in treating stress-related conditions – study

What is CBDA? Raw cannabinoids and their potential benefits

By |2023-09-19T03:25:48+01:0019 September 2023|

While not as well-known as CBD or THC, raw cannabinoids such as cannabidiolic acid (CBDA), are becoming more popular due to their potential health and wellness benefits. The term ‘raw cannabinoids’ refers to the chemical compounds found in the cannabis plant in their natural form, before [...]

Comments Off on What is CBDA? Raw cannabinoids and their potential benefits

Lyphe Group and Boveda forge partnership for UK cannabis patients

By |2023-09-15T03:20:51+01:0015 September 2023|

UK medical cannabis company, Lyphe Group, has announced a new partnership to enhance how patients receive their cannabis prescriptions.  In what is thought to be an industry first, Lyphe Group’s dispensing pharmacy, Dispensary Green, has partnered with Boveda Inc, a global leader in two-way humidity control, [...]

Comments Off on Lyphe Group and Boveda forge partnership for UK cannabis patients

BBC documentary highlights ‘pot luck’ of access to cannabis on NHS

By |2023-09-15T03:20:37+01:0015 September 2023|

Approaching five years since medical cannabis was legalised in the UK, a new BBC documentary accuses the government of misleading the public over its availability on the NHS.  On 1 November, 2023 medical cannabis will have been legally available on prescription in the UK for five [...]

Comments Off on BBC documentary highlights ‘pot luck’ of access to cannabis on NHS

NIDA funds $3.69m study on role of genetics in response to THC

By |2023-09-15T03:20:23+01:0015 September 2023|

Researchers have received a $3.69 million grant from the National Institute on Drug Abuse (NIDA) to study how genetic differences influence behavioural and physiological responses to tetrahydrocannabinol (THC). Increased legalisation of medical and/or recreational cannabis and more favourable public perspectives has led to an increase in [...]

Comments Off on NIDA funds $3.69m study on role of genetics in response to THC

Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study

By |2023-09-14T03:05:32+01:0014 September 2023|

Researchers behind a new study say medicinal cannabis is not only effective and fast-acting in the treatment of neuropathic pain, but also has fewer side-effects than conventional medicines.  A retrospective study, conducted by scientists from the University Medical Center Hamburg-Eppendorf (UKE Hamburg) in Germany in cooperation [...]

Comments Off on Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study

CanXChange introduces revolutionary CX financing Service, redefining industry standards

By |2023-09-13T03:05:21+01:0013 September 2023|

CanXChange, the largest B2B cannabis platform in Europe and a leading financial technology company, is proud to announce the launch of its newest service, CX Financing. This innovative product is set to transform the receivables financing landscape, offering exclusive credit terms to our esteemed partners and [...]

Comments Off on CanXChange introduces revolutionary CX financing Service, redefining industry standards

“As a disabled person and full-time carer, cannabis enables me to support my partner”

By |2023-09-13T03:05:10+01:0013 September 2023|

After years of pain medication and antidepressants, Kerry Davies came off all her NHS prescription drugs when she started consuming cannabis medicinally. Here, she shares her journey so far. Kerry Davies battles daily with the symptoms of fibromyalgia and PTSD, as well as her history of [...]

Comments Off on “As a disabled person and full-time carer, cannabis enables me to support my partner”

Study sheds light on anti-inflammatory action of cannabinoids

By |2023-09-12T03:03:10+01:0012 September 2023|

Researchers in Germany have shed new light on how cannabinoids could potentially reduce inflammation in the body, with CBD found to be particularly effective. Friedrich-Schiller-Universitaet Jena in Germany, have been investigating how certain compounds found in the cannabis plant work to counteract inflammation in the body.  [...]

Comments Off on Study sheds light on anti-inflammatory action of cannabinoids

Cannabis-in-brief: US rescheduling, wider NHS access, Long Covid and workplace discrimination

By |2023-09-09T03:12:20+01:009 September 2023|

We bring you the news you might have missed from the week just gone. The top lines: Health officials in the US have recommended that cannabis be rescheduled to a ‘lower risk’ drug, while the UK Home Affairs Committee called for wider access to cannabis on [...]

Comments Off on Cannabis-in-brief: US rescheduling, wider NHS access, Long Covid and workplace discrimination

Switzerland’s ‘pragmatic not political’ approach to cannabis reform should set precedent

By |2023-09-09T03:12:06+01:009 September 2023|

Via Business of Cannabis  As Switzerland sees the launch of its second cannabis pilot, Cannavigia co-founder Philipp Hagenbach, shares his insights on the country’s approach to reform. Recent weeks have seen the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2,000 Zurich inhabitants [...]

Comments Off on Switzerland’s ‘pragmatic not political’ approach to cannabis reform should set precedent

Prescription cannabis patients at risk of discrimination in the workplace, says report

By |2023-09-08T03:11:44+01:008 September 2023|

Employers may be breaching the Equality Act over their approach to prescription cannabis patients in the workplace, according to a new report. What are your rights as an employer and an employee? Published by the Cannabis Industry Council (CIC), ‘The Use of Prescription Cannabis at Work’, [...]

Comments Off on Prescription cannabis patients at risk of discrimination in the workplace, says report

Cannabis linked to improvements in fatigue and quality of life – study

By |2023-09-08T03:11:31+01:008 September 2023|

Australian patients with chronic health issues showed significant improvements in overall health-related quality of life and fatigue in the first three months of treatment with medical cannabis, a new study has found. The paper, published in the journal PLOS ONE, also noted that participants reported improvements [...]

Comments Off on Cannabis linked to improvements in fatigue and quality of life – study

How cannabis could help manage the unmet need in endometriosis

By |2023-09-07T03:14:06+01:007 September 2023|

Endometriosis is a chronic inflammatory disorder that affects 10% of all women between the ages of 12 and 80 years old and for which there is an urgent need for new treatment options. Here, experts at SOMAÍ Pharmaceuticals explore how cannabis could be part of the [...]

Comments Off on How cannabis could help manage the unmet need in endometriosis

US: Rising rates of cannabis use among older adults are ‘no surprise’

By |2023-09-07T03:13:46+01:007 September 2023|

With cannabis use reaching its highest recorded levels among older adults in the US, this generation may finally be recognising its potential enhancing health and wellbeing. Insights from a recent federally-funded survey in the US suggest that cannabis use has risen significantly in the last decade, [...]

Comments Off on US: Rising rates of cannabis use among older adults are ‘no surprise’

Potential of cannabis in treating Long Covid warrants further research

By |2023-09-06T03:07:13+01:006 September 2023|

The role of cannabis-based medicines in treating the symptoms of Long Covid warrants further investigation, according to a new review. UK researchers say existing evidence supports the use of cannabis as a potential treatment for Long Covid, including for symptoms of sleep disturbance, fatigue, pain and [...]

Comments Off on Potential of cannabis in treating Long Covid warrants further research

Are disposable CBD vapes bad for the environment?

By |2023-09-05T03:18:10+01:005 September 2023|

Vaping is a popular way of consuming CBD, but there’s a dark side to the disposable vapes which have flooded the market in recent years. As we previously explored, vaping is an increasingly popular way of administering CBD, mainly due to its fast-acting effects and its [...]

Comments Off on Are disposable CBD vapes bad for the environment?

Home Affairs Committee calls for wider NHS access to medical cannabis

By |2023-09-02T03:02:01+01:002 September 2023|

In its latest report on drugs, the UK Home Affairs Committee recommends that the government widens access to cannabis medicines on the NHS, but cites ‘concerns’ over non-medical use.  The new report, published by the Home Affairs Committee on Thursday 31 August, sets out a number [...]

Comments Off on Home Affairs Committee calls for wider NHS access to medical cannabis

Top US health officials recommend rescheduling cannabis

By |2023-09-01T03:00:55+01:001 September 2023|

The US Department of Health and Human Services (HHS), has recommended that cannabis be classed as a lower risk drug. Here’s what this means for research, industry and consumers. A leaked letter, seen by Bloomberg News and dated Tuesday 29 August, reveals that the HHS has [...]

Comments Off on Top US health officials recommend rescheduling cannabis

The state of pharmaceutical cannabis – 12 key takeaways

By |2023-08-31T03:14:19+01:0031 August 2023|

A new report explores the progression of cannabis research over the last decade, as well as the barriers holding back further developments in the pharmaceutical space. We take a look at some of the key takeaways. The report, published today by Prohibition Partners and Cannabiscientia, gives [...]

Comments Off on The state of pharmaceutical cannabis – 12 key takeaways

Cannabis may be beneficial in childhood cancer, but more evidence is needed

By |2023-08-31T03:14:01+01:0031 August 2023|

Cannabinoids may be beneficial for managing symptoms in children with cancer, a new review finds, but more extensive research is needed.  A recent analysis of existing research suggests that while cannabinoids are increasingly being used to manage symptoms in childhood cancer, there is a lack of [...]

Comments Off on Cannabis may be beneficial in childhood cancer, but more evidence is needed

UK Home Office urged to provide clarity for CBD industry

By |2023-08-30T03:05:00+01:0030 August 2023|

Representatives of the UK CBD industry are urging the Home Office to protect the sector, and reassure millions of consumers, with greater clarity and stricter regulation. A new campaign, led by the Association for the Cannabinoid Industry (ACI), is calling on the Home Office to implement [...]

Comments Off on UK Home Office urged to provide clarity for CBD industry

Study: Cannabis ‘not associated’ with increased rates of psychosis in ‘high risk’ teenagers

By |2023-08-30T03:04:47+01:0030 August 2023|

In a new study, cannabis was not associated with increased rates of psychosis or other adverse health outcomes among adolescents classed as ‘high risk’ for the disorder. Researchers at Hofstra University in New York and Stanford University in California, assessed the relationship between cannabis use and [...]

Comments Off on Study: Cannabis ‘not associated’ with increased rates of psychosis in ‘high risk’ teenagers

Cannabis-in-brief: Zürich launches adult-use pilot, Israel’s medical cannabis reforms and global health economic study

By |2023-08-28T12:58:25+01:0028 August 2023|

We bring you the news you might have missed from the week just gone. The top lines this week: The Swiss city of Zürich launches its adult-use cannabis pilot, Israel’s major reforms aim to make medical cannabis a ‘first line treatment’, and a global study will [...]

Comments Off on Cannabis-in-brief: Zürich launches adult-use pilot, Israel’s medical cannabis reforms and global health economic study

From last resort to first line: Israel’s major reforms to medical cannabis

By |2023-08-28T12:57:57+01:0028 August 2023|

Via Business of Cannabis  Israel could soon see a dramatic increase in the number of medical cannabis patients as the government publishes proposals for sweeping reforms aimed at streamlining access. On Monday 7 August, The Health Ministry published its highly anticipated proposals for medical cannabis reform in [...]

Comments Off on From last resort to first line: Israel’s major reforms to medical cannabis

The doctor’s perspective: medical cannabis in ADHD and autism

By |2023-11-07T11:35:34+00:0028 August 2023|

In his final instalment, consultant psychiatrist and cannabis clinician Dr Tahzid Ahsan, explores the potential of cannabis in managing symptoms of ADHD and autism. Around three in 10 autistic adults and around 28% of autistic children also have ADHD. The likelihood of someone presenting with both [...]

Comments Off on The doctor’s perspective: medical cannabis in ADHD and autism

Best of cannabinoid science: Alzheimer’s, binge eating disorder, ageing and hair growth

By |2023-08-28T12:57:16+01:0028 August 2023|

Cannabis scientist Lex Pelger brings you the latest cannabinoid research with new studies exploring CBD for ageing and hair growth, plus fibromyalgia, Alzheimer’s, binge eating disorder and more.  Lex Pelger is a biochemist specialising in cannabinoids and psychedelics. Here we share an extract from his newsletter, [...]

Comments Off on Best of cannabinoid science: Alzheimer’s, binge eating disorder, ageing and hair growth

Switzerland launches second cannabis pilot with support of Cannavigia software

By |2023-08-28T12:57:03+01:0028 August 2023|

The Swiss city of Zurich has marked a significant milestone with the official launch of its cannabis pilot trial ‘ZüriCan’ this week.  The trials represent a major development in the legalisation and regulation of cannabis in Switzerland.  The second pilot, which began on Tuesday 22 August, [...]

Comments Off on Switzerland launches second cannabis pilot with support of Cannavigia software

Study: patients say medical cannabis improves job performance

By |2023-08-28T12:56:49+01:0028 August 2023|

A new study highlights the myriad of benefits medical cannabis can have on patients’ quality of life, from reducing symptoms to boosting energy levels and job performance.  Researchers in Greece studied a group of patients receiving medical cannabis treatment to try to understand how it impacted [...]

Comments Off on Study: patients say medical cannabis improves job performance

Report reveals countries leading the way in cannabis-related clinical trials

By |2023-08-28T12:56:29+01:0028 August 2023|

After the US, the UK saw the second highest number of clinical trials carried out on cannabinoids in the last decade, according to a new report.  The upcoming report, due to be published this month by Prohibition Partners and Cannabiscientia, explores the progression of cannabis research [...]

Comments Off on Report reveals countries leading the way in cannabis-related clinical trials

Global study to explore health economic benefits of medical cannabis

By |2023-08-28T12:56:19+01:0028 August 2023|

Researchers in Australia will explore whether treatment with medicinal cannabis can ease the economic impact of chronic health conditions. Australians living with one of 200 chronic conditions may now be eligible to participate in what is expected to become the world’s largest study into the impact [...]

Comments Off on Global study to explore health economic benefits of medical cannabis

Irish cannabis ‘caregiver’ serving ‘disproportionate’ five-year sentence moved to open prison

By |2023-08-28T12:56:02+01:0028 August 2023|

A dad-of-two, serving five years for supplying cannabis to help severely ill patients, has been moved to an open prison as his family prepare to launch an appeal against his sentence. The family of Patrick Moore, who was sentenced to five years for the cultivation and [...]

Comments Off on Irish cannabis ‘caregiver’ serving ‘disproportionate’ five-year sentence moved to open prison

Cannabis-in-brief: Germany moves closer to reform, Malta grants first association licences and NHS to fund CBD trial

By |2023-08-19T03:05:30+01:0019 August 2023|

We bring you the news you might have missed from the week just gone. The top lines this week: The German Cabinet approved a bill to implement the first phase of adult-use cannabis legalisation, while Malta moves to issue its first cannabis association licences. In the [...]

Comments Off on Cannabis-in-brief: Germany moves closer to reform, Malta grants first association licences and NHS to fund CBD trial

US: Medical cannabis lowers health insurance premiums – study

By |2023-08-19T03:05:24+01:0019 August 2023|

A new study has found that states which have legalised medical cannabis have seen a drop in the average cost of individual healthcare premiums. Researchers from Bowling Green State University in Ohio and Illinois State University looked at the impact of state-specific medical cannabis legalisation laws [...]

Comments Off on US: Medical cannabis lowers health insurance premiums – study

Malta issues first two Cannabis Association licences ‘in principle’

By |2023-08-19T03:05:05+01:0019 August 2023|

Via Business of Cannabis The head of Malta’s cannabis regulatory body has confirmed reports that the country’s first two cannabis associations have been granted licences, ‘in-principle’. Two years after Malta first moved to allow the consumption and cultivation of cannabis for adult-use, the Authority for the Responsible [...]

Comments Off on Malta issues first two Cannabis Association licences ‘in principle’

NHS Scotland to fund clinical trial on CBD and endometriosis

By |2023-08-18T03:07:14+01:0018 August 2023|

NHS Scotland is funding a six-figure clinical trial to explore the effects of CBD on pelvic pain related to endometriosis.  The Chief Scientist Office, part of the Scottish Government Health Directorate responsible for funding research in NHS Scotland, will provide £300,000 for the trial, Ananda Developments, [...]

Comments Off on NHS Scotland to fund clinical trial on CBD and endometriosis

Germany launches harm-reduction campaign as cabinet approves adult-use cannabis bill

By |2023-08-18T03:06:41+01:0018 August 2023|

The German Cabinet has passed a bill for the first phase of adult-use cannabis reform, whilst demonstrating its commitment to harm-reduction and youth protection.  On Wednesday, members of the German cabinet passed the draft of a bill which will see the country take its first steps [...]

Comments Off on Germany launches harm-reduction campaign as cabinet approves adult-use cannabis bill

New study sheds light on effects of HHC in the body

By |2023-08-17T03:01:55+01:0017 August 2023|

A new study by researchers in the US is the first to shed light on how HHC binds to receptors in the body – and proposes a safer, more consistent way to produce them. The new paper takes a closer look at hexahydrocannabinol, or HHC, an [...]

Comments Off on New study sheds light on effects of HHC in the body

UK research finds GP support for cannabis as an alternative to opioids for chronic pain

By |2023-08-17T03:01:20+01:0017 August 2023|

New research suggests a growing awareness and interest in medical cannabis as an alternative to opioid medications among GPs practising in the UK. Almost two-fifths (37%) of GPs believe that medical cannabis has the potential to reduce patient dependency on other medications and improve quality of [...]

Comments Off on UK research finds GP support for cannabis as an alternative to opioids for chronic pain

The dark side of CBD in fitness – risks you need to know

By |2023-08-15T03:44:41+01:0015 August 2023|

As CBD becomes increasingly popular among athletes, Scott Mazza, COO and co-founder of Vitality CBD, shares some tips for using it safely in sport. CBD is taking the fitness world by storm. With evidence showing the compound helps to reduce inflammation, improve recovery and promote focus [...]

Comments Off on The dark side of CBD in fitness – risks you need to know

How is CBD different from medical cannabis?

By |2023-08-12T03:25:14+01:0012 August 2023|

Ahead of National CBD day on Saturday 8 August, we explore some of the key differences between CBD wellness products and prescribed medical cannabis. While legalisation of recreational cannabis is far off in this country, medical cannabis has been legal since 2018 – yet over half [...]

Comments Off on How is CBD different from medical cannabis?

What are the barriers facing Spanish medical cannabis access?

By |2023-08-11T03:09:07+01:0011 August 2023|

Following another recent disappointment for Spanish patients, Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals explores the barriers preventing the regulation of medical cannabis in the country. What is wrong with medical cannabis access in Spain? In short: Politics! Spain has long been the most head-scratching [...]

Comments Off on What are the barriers facing Spanish medical cannabis access?

How safe is vaping CBD? Everything you need to know

By |2023-08-10T03:35:48+01:0010 August 2023|

Vaping is a popular way to consume CBD, but how safe is it? We take a look at the potential benefits, effects and risks. While tinctures and oils have conventionally been the most common way of getting a dose of CBD’s potential health and wellness benefits, [...]

Comments Off on How safe is vaping CBD? Everything you need to know

Althea secures approval of cannabis-based oil through Ireland’s MCAP

By |2023-08-09T03:04:52+01:009 August 2023|

Althea’s cannabis-based oil has been given the green light from Ireland’s regulators to be prescribed free of charge through the Medical Cannabis Access Programme (MCAP).  The global manufacturer of cannabis-based medicines has successfully secured approval from The Republic of Ireland’s Primary Care Reimbursement Service for its [...]

Comments Off on Althea secures approval of cannabis-based oil through Ireland’s MCAP

‘Landmark’ ruling gives hope for UK CBD flower businesses

By |2023-08-08T03:22:43+01:008 August 2023|

Via Business of Cannabis  A ‘landmark’ Court of Appeal ruling in the UK has set a new legal precedent for businesses in the UK importing and selling CBD or low-THC hemp flower. Crucially, the Court of Appeal has made it clear that it does not consider hemp flower [...]

Comments Off on ‘Landmark’ ruling gives hope for UK CBD flower businesses

Study finds no link between high-THC cannabis and psychosis

By |2023-08-05T03:07:40+01:005 August 2023|

Researchers have found little evidence of a link between high potency cannabis and an increased risk of psychosis and other mental health symptoms. A team of researchers at the University of Bath have explored the association between cannabis potency and the likelihood of developing cannabis dependence [...]

Comments Off on Study finds no link between high-THC cannabis and psychosis

UK study finds most products contain less CBD than advertised

By |2023-08-04T03:13:14+01:004 August 2023|

In a new study of the CBD content in products on sale in the UK, the majority were found to contain significantly lower concentrations than what was advertised. Researchers analysed the actual concentrations of CBD in a sample of products on sale in the UK and [...]

Comments Off on UK study finds most products contain less CBD than advertised

Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure

By |2023-08-04T03:12:57+01:004 August 2023|

We’ve rounded up some of the most recent research in the field of cannabis medicine, including its potential therapeutic effects in a number of debilitating chronic conditions. While more studies are needed, new findings indicate potential for cannabis as a tool to manage symptoms of amyotrophic [...]

Comments Off on Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure

NHS approves major clinical trial on cannabis medicines and chronic pain

By |2023-08-03T03:03:21+01:003 August 2023|

A clinical trial investigating the efficacy of cannabis-based medicines in up to 5,000 patients with chronic pain has been given the green light from UK regulators. Celadon Pharmaceuticals, a licensed producer of cannabis-based medicines in the UK and is private pain clinic, LVL Health, have received [...]

Comments Off on NHS approves major clinical trial on cannabis medicines and chronic pain